McLaughlin Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
3,567
+286
+9% +$19.1K 0.17% 90
2026
Q1
$206K Sell
3,281
-323
-9% -$22.5K 0.2% 91
2025
Q4
$239K Buy
+3,604
New +$233K 0.21% 85

Other funds holding DXCM

McLaughlin Asset Management's DXCM Position: Q2 2026 in Review

McLaughlin Asset Management increased its DexCom (DXCM) stake by 8.7% in Q2 2026, buying an estimated $19.1K and bringing the position to 3,567 shares worth $240K. The position accounts for 0.17% of the portfolio, ranked #90.

McLaughlin Asset Management first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • McLaughlin Asset Management held 3,567 shares of DexCom worth $240K as of Q2 2026.
  • McLaughlin Asset Management bought 286 DexCom shares in Q2 2026, an estimated $19.1K.
  • DexCom made up 0.17% of McLaughlin Asset Management's portfolio in Q2 2026, its #90 holding.
  • McLaughlin Asset Management first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on McLaughlin Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.